ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KPTI Karyopharm Therapeutics Inc

1.075
-0.015 (-1.38%)
Last Updated: 12:54:54
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Karyopharm Therapeutics Inc KPTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.015 -1.38% 1.075 12:54:54
Open Price Low Price High Price Close Price Prev Close
1.10 1.05 1.15 1.09
more quote information »

Recent News

Date Time Source Heading
4/01/202416:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
3/06/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:05PRNUSKaryopharm to Participate at Barclays 26th Annual Global..
3/04/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202416:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
2/29/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202407:43EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202407:35EDGAR2Form 8-K - Current report
2/29/202407:30PRNUSKaryopharm Reports Fourth Quarter and Full Year 2023..
2/22/202407:00PRNUSKaryopharm to Report Fourth Quarter and Full Year 2023..
2/20/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202408:00EDGAR2Form 8-K - Current report
2/14/202410:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202406:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202416:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
1/25/202419:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202419:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202418:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202408:40EDGAR2Form 8-K - Current report
1/08/202408:30PRNUSKaryopharm Announces Preliminary Unaudited 2023 Revenue and..
1/03/202407:00PRNUSKaryopharm to Present at 42nd Annual J.P. Morgan Healthcare..
1/02/202416:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
12/12/202316:05EDGAR2Form 8-K - Current report
12/10/202320:15PRNUSKaryopharm Shares Data at ASH 2023 Showing Strong SVR and..
12/05/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202316:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
11/08/202316:05PRNUSKaryopharm to Participate at Upcoming Investor Conferences
11/07/202317:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/06/202307:00PRNUSKaryopharm Announces New Preliminary Data in Overall..
11/02/202309:20PRNUSKaryopharm Announces Presentations at the 65th American..
11/02/202307:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202307:37EDGAR2Form 8-K - Current report
11/02/202307:30PRNUSKaryopharm Reports Third Quarter 2023 Financial Results and..
10/30/202308:00PRNUSKaryopharm Announces Clinical Trial Collaboration with..

Your Recent History

Delayed Upgrade Clock